$HIMS
Hims & Hers Health, Inc. Stock $hims

$hims Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000177375122000118 Filed on May 09, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$101.3M	$52.31M
YoY Change	93.67%	74.01%
Cost Of Revenue	$26.56M	$12.07M
YoY Change	120.09%	27.77%
Gross Profit	$74.76M	$40.25M
YoY Change	85.74%	95.19%
Gross Profit Margin	73.79%	76.93%
Selling, General & Admin	$43.58M	$61.70M
YoY Change	-29.36%	338.69%
% of Gross Profit	58.3%	153.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.741M	$394.0K
YoY Change	341.88%	118.89%
% of Gross Profit	2.33%	0.98%
Operating Expenses	$91.68M	$88.66M
YoY Change	3.41%	230.35%
Operating Profit	-$16.92M	-$48.41M
YoY Change	-65.05%	678.53%
Interest Expense	$616.0K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$761.0K	-$2.905M
YoY Change	-126.2%	-1363.04%
Pretax Income	-$16.16M	-$51.31M
YoY Change	-68.51%	755.52%
Income Tax	$94.00K	$90.00K
% Of Pretax Income
Net Earnings	-$16.25M	-$51.40M
YoY Change	-68.38%	752.05%
Net Earnings / Revenue	-16.04%	-98.26%
Basic Earnings Per Share	-$0.08	-$0.34
Diluted Earnings Per Share	-$0.08	-$0.34
COMMON SHARES
Basic Shares Outstanding	202.7M shares	153.1M shares
Diluted Shares Outstanding	202.7M shares	153.1M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$203.1M	$323.3M
YoY Change	-37.19%	21451.07%
Cash & Equivalents	$48.28M	$88.17M
Short-Term Investments	$154.8M	$235.1M
Other Short-Term Assets	$1.236M	$5.000K
YoY Change	24620.0%	-95.0%
Inventory	$12.14M	$4.523M
Prepaid Expenses	$10.05M	$8.650M
Receivables	$5.463M	$942.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$231.9M	$340.2M
YoY Change	-31.82%	21174.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.787M
YoY Change
Goodwill	$110.9M
YoY Change
Intangibles	$24.85M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.721M	$4.848M
YoY Change	79.89%
Total Long-Term Assets	$150.1M	$5.704M
YoY Change	2531.36%	-97.21%
TOTAL ASSETS
Total Short-Term Assets	$231.9M	$340.2M
Total Long-Term Assets	$150.1M	$5.704M
Total Assets	$382.0M	$345.9M
YoY Change	10.45%	67.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.91M	$13.23M
YoY Change	80.65%	17649.55%
Accrued Expenses	$9.089M	$5.823M
YoY Change	56.09%	942.4%
Deferred Revenue	$1.145M	$624.0K
YoY Change	83.49%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$48.50M	$19.68M
YoY Change	146.44%	1585.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$517.0K	$33.75M
YoY Change	-98.47%	368.81%
Total Long-Term Liabilities	$517.0K	$33.75M
YoY Change	-98.47%	368.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.50M	$19.68M
Total Long-Term Liabilities	$517.0K	$33.75M
Total Liabilities	$54.32M	$53.43M
YoY Change	1.67%	539.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$295.2M	-$222.7M
YoY Change	32.56%	-9075.03%
Common Stock	$623.2M	$515.2M
YoY Change	20.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$327.7M	$292.5M
YoY Change
Total Liabilities & Shareholders Equity	$382.0M	$345.9M
YoY Change	10.45%	67.68%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$16.25M	-$51.40M
YoY Change	-68.38%	752.05%
Depreciation, Depletion And Amortization	$1.741M	$394.0K
YoY Change	341.88%	118.89%
Cash From Operating Activities	-$19.40M	-$15.95M
YoY Change	21.66%	207.22%
INVESTING ACTIVITIES
Capital Expenditures	-$1.297M	-$803.0K
YoY Change	61.52%
Acquisitions
YoY Change
Other Investing Activities	$19.75M	-$162.5M
YoY Change	-112.15%
Cash From Investing Activities	$18.45M	-$163.3M
YoY Change	-111.3%	-2358.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$22.03M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$22.53M	$239.9M
YoY Change	-109.39%	690.98%
NET CHANGE
Cash From Operating Activities	-$19.40M	-$15.95M
Cash From Investing Activities	$18.45M	-$163.3M
Cash From Financing Activities	-$22.53M	$239.9M
Net Change In Cash	-$23.50M	$60.68M
YoY Change	-138.73%	87.45%
FREE CASH FLOW
Cash From Operating Activities	-$19.40M	-$15.95M
Capital Expenditures	-$1.297M	-$803.0K
Free Cash Flow	-$18.11M	-$15.15M
YoY Change	19.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001773751
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	HIMS & HERS HEALTH, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity File Number EntityFileNumber	001-38986
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1482650
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2269 Chestnut Street, #523
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7942000	USD
CY2022Q1	us-gaap	Assets Assets	382039000	USD
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94123
CY2022Q1	dei	City Area Code CityAreaCode	415
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	851-0195
CY2022Q1	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	HIMS
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48284000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71784000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	154769000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	175490000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12143000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13558000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16750000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9073000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	231946000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	269905000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	110881000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	110881000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24848000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25890000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4787000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5111000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8721000	USD
CY2021Q4	us-gaap	Assets Assets	420585000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	23906000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19640000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9089000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12194000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1145000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3188000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	12972000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	42834000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1388000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1365000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	48500000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	79221000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3763000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4117000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1544000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	517000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	629000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1999000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	54324000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	85966000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	21000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	20000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	623220000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	613687000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-323000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-137000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-295203000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-278951000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	327715000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	334619000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	382039000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	420585000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101314000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52314000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	26558000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	12067000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	74756000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	40247000	USD
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	48093000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	26958000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43582000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	61698000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	91675000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	88656000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16919000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	320000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-48409000	USD
CY2022Q1	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	-441000	USD
CY2021Q1	hims	Fair Value Adjustment Of Liabilities FairValueAdjustmentOfLiabilities	2681000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-224000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	761000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2905000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16158000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51314000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	94000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16252000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-51404000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-186000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-61000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16438000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51465000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	202695970	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	202695970	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153080538	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153080538	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	334619000	USD
CY2022Q1	hims	Share Based Payment Arrangement Payment For Taxes Related To Net Share Settlement Of Equity Awards ShareBasedPaymentArrangementPaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	404000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	891000	USD
CY2022Q1	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	38000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9009000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-186000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16252000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	327715000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-146874000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21902000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	249837000	USD
CY2021Q1	hims	Adjustments To Additional Paid In Capital Related Party Receivable Repayment AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment	854000	USD
CY2021Q1	hims	Adjustments To Additional Paid In Capital Warrant Conversion AdjustmentsToAdditionalPaidInCapitalWarrantConversion	1160000	USD
CY2021Q1	hims	Stock Exercised During Period Value Common Stock Warrants StockExercisedDuringPeriodValueCommonStockWarrants	21678000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	16200000	USD
CY2021Q1	hims	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	129659000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75000000	USD
CY2021Q1	hims	Stock Issued During Period Value Earn Out StockIssuedDuringPeriodValueEarnOut	1000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	80000	USD
CY2021Q1	hims	Adjustments To Additional Paid In Capital Early Exercised Options Vested AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested	54000	USD
CY2021Q1	hims	Adjustments To Additional Paid In Capital Recapitalization Warrant Expense AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense	154000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34230000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-61000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-51404000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	292466000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16252000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-51404000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1741000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	394000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8856000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	34230000	USD
CY2022Q1	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	441000	USD
CY2021Q1	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-2681000	USD
CY2022Q1	hims	Noncash Warrant Expense NoncashWarrantExpense	0	USD
CY2021Q1	hims	Noncash Warrant Expense NoncashWarrantExpense	154000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	144000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-971000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-287000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-112000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2022Q1	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-377000	USD
CY2021Q1	hims	Noncash Operating Lease Costs NoncashOperatingLeaseCosts	-378000	USD
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	94000	USD
CY2021Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-165000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1415000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	980000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7677000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7147000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	30000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4266000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5117000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3148000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1114000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2043000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-648000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-384000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-375000	USD
CY2022Q1	hims	Increase Decrease In Business Combination Contingent Consideration Liability Current IncreaseDecreaseInBusinessCombinationContingentConsiderationLiabilityCurrent	-6848000	USD
CY2021Q1	hims	Increase Decrease In Business Combination Contingent Consideration Liability Current IncreaseDecreaseInBusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19403000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15948000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	84881000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	172021000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	82340000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9500000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	22291000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	1197000	USD
CY2021Q1	us-gaap	Payments For Software PaymentsForSoftware	740000	USD
CY2022Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	100000	USD
CY2021Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	63000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18453000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163324000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22027000	USD
CY2022Q1	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	0	USD
CY2021Q1	hims	Proceeds From Issuance Of Common Stock Recapitalization ProceedsFromIssuanceOfCommonStockRecapitalization	197686000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	75000000	USD
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	12794000	USD
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1193000	USD
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	807000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	891000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	80000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	404000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	23014000	USD
CY2021Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22527000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	239945000	USD
CY2022Q1	us-gaap	Recapitalization Costs RecapitalizationCosts	0	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-23000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23500000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	60675000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72640000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28350000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49140000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89025000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48284000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	88169000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	856000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49140000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89025000	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	36000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	59000	USD
CY2021Q1	us-gaap	Recapitalization Costs RecapitalizationCosts	125000	USD
CY2022Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	249837000	USD
CY2022Q1	hims	Warrants Assumed WarrantsAssumed	0	USD
CY2021Q1	hims	Warrants Assumed WarrantsAssumed	51814000	USD
CY2022Q1	hims	Warrants Exercised WarrantsExercised	0	USD
CY2021Q1	hims	Warrants Exercised WarrantsExercised	20871000	USD
CY2022Q1	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	0	USD
CY2021Q1	hims	Conversion Of Preferred Stock Warrants Amount Converted ConversionOfPreferredStockWarrantsAmountConverted	1160000	USD
CY2022Q1	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	38000	USD
CY2021Q1	hims	Vesting Of Early Exercised Stock Options Net Of Cancelations VestingOfEarlyExercisedStockOptionsNetOfCancelations	54000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation of contingent consideration in business combinations, purchase price allocation for business combinations, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management’s estimates. To the extent that there are material differences between these estimates and actual results, the Company’s condensed consolidated financial statements will be affected.
CY2022Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingUnit
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	110900000	USD
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101314000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	52314000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	154981000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	212000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	154769000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	175539000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	49000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	175490000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7883000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10428000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4260000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3130000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12143000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	13558000	USD
CY2022Q1	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	5463000	USD
CY2021Q4	hims	Wholesale Trade Receivables Current WholesaleTradeReceivablesCurrent	3577000	USD
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10051000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4606000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1236000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	890000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16750000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9073000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28016000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3168000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24848000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28016000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2126000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25890000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3124000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3542000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2801000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2672000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2455000	USD
CY2022Q1	hims	Finite Lived Intangible Asset Expected Amortization Year Five And Thereafter FiniteLivedIntangibleAssetExpectedAmortizationYearFiveAndThereafter	10254000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24848000	USD
CY2022Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2322000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	3158000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1007000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2686000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3363000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	954000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	812000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	734000	USD
CY2022Q1	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	761000	USD
CY2021Q4	hims	Product And Shipping Costs Current ProductAndShippingCostsCurrent	2635000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1501000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1350000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9089000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12194000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	100000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	100000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	384000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	375000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6756000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1175000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1598000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1638000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1114000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5525000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	374000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5151000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5200000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1400000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3800000	USD
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Three ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree	20.00
CY2022Q1	us-gaap	Purchase Obligation PurchaseObligation	2300000	USD
CY2022Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	1200000	USD
CY2022Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	1100000	USD
CY2022Q1	hims	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	commonStockClass
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.71
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3300000	USD
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	14859000	shares
CY2022Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	8066000	shares
CY2021Q1	hims	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.4530
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger One ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne	15.00
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Stock Price Trigger Two ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo	17.50
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays	10	day
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays	20	day
CY2021Q1	hims	Reverse Recapitalization Contingent Consideration Equity Earnout Period ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriod	P5Y
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8856000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34230000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	200000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002

Files In Submission

Name	View Source	Status
0001773751-22-000118-index-headers.html	Edgar Link	pending
0001773751-22-000118-index.html	Edgar Link	pending
0001773751-22-000118.txt	Edgar Link	pending
0001773751-22-000118-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hims-20220331.htm	Edgar Link	pending
hims-20220331.xsd	Edgar Link	pending
hims-20220331x10qxex311.htm	Edgar Link	pending
hims-20220331x10qxex312.htm	Edgar Link	pending
hims-20220331x10qxex321.htm	Edgar Link	pending
hims-20220331x10qxex322.htm	Edgar Link	pending
hims-20220331_cal.xml	Edgar Link	unprocessable
hims-20220331_def.xml	Edgar Link	unprocessable
hims-20220331_htm.xml	Edgar Link	completed
hims-20220331_lab.xml	Edgar Link	unprocessable
hims-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HIMS
Hims & Hers Health, Inc. Stock $hims

2022 Q1 Form 10-Q Financial Statement

#000177375122000118 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS Hims & Hers Health, Inc. Stock $hims

2022 Q1 Form 10-Q Financial Statement

#000177375122000118 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HIMS
Hims & Hers Health, Inc. Stock $hims